Invention Application
US20120077797A1 OXOPIPERAZINE-AZETIDINE AMIDES AND OXODIAZEPINE-AZETIDINE AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS
失效
作为单加性胆碱酯酶抑制剂的奥西维他嗪 - 阿魏酸和氧化吖嗪 - 阿魏酸
- Patent Title: OXOPIPERAZINE-AZETIDINE AMIDES AND OXODIAZEPINE-AZETIDINE AMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS
- Patent Title (中): 作为单加性胆碱酯酶抑制剂的奥西维他嗪 - 阿魏酸和氧化吖嗪 - 阿魏酸
-
Application No.: US13246232Application Date: 2011-09-27
-
Publication No.: US20120077797A1Publication Date: 2012-03-29
- Inventor: Peter J. Connolly , Mark J. Macielag , Mark E. McDonnell , Bin Zhu
- Applicant: Peter J. Connolly , Mark J. Macielag , Mark E. McDonnell , Bin Zhu
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61P25/00 ; A61K31/496 ; C07D417/14 ; C07D409/14 ; C07D403/04

Abstract:
Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds, and enantiomers, diastereomers, and pharmaceutically acceptable salts thereof, are represented by Formula (Ia) and Formula (Ib) as follows: wherein Y, Z, and n are defined herein; and wherein Yb and Zb are as defined herein.
Public/Granted literature
- US08637498B2 Oxopiperazine-azetidine amides and oxodiazepine-azetidine amides as monoacylglycerol lipase inhibitors Public/Granted day:2014-01-28
Information query
IPC分类: